Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum computing promises transformative returns, yet IonQ’s SEC documents can read like a physics dissertation. Locating R&D burn rates, deciphering option grants, or spotting dilution warnings inside a single IonQ annual report 10-K simplified often takes hours. Stock Titan eliminates that pain. Our AI delivers IonQ SEC filings explained simply, showing the numbers and milestones without the math PhD.
Every time IonQ hits the EDGAR tape, we post the filing within seconds and pair it with machine-written context. Need the next IonQ quarterly earnings report 10-Q filing or an IonQ 8-K material events explained? It’s already summarized. Want alerts the moment a director sells shares? Our feed of IonQ Form 4 insider transactions real-time keeps you ahead. Below you’ll find:
- 10-K & 10-Q breakdowns highlighting cash runway, government contract backlog, and qubit roadmaps.
- Form 4 dashboards for IonQ insider trading Form 4 transactions and IonQ executive stock transactions Form 4.
- Proxy statement insights detailing IonQ proxy statement executive compensation.
- Instant notes on 8-K releases, mergers, or financing updates.
Use these AI summaries to compare quarter-over-quarter progress, monitor insider sentiment, or share concise takeaways with clients. Whether you’re modeling cash needs or validating strategic milestones, understanding IonQ SEC documents with AI turns dense disclosures into actionable clarity. Save time, catch details others miss, and rely on our IonQ earnings report filing analysis to stay informed about the company pushing quantum boundaries.
IonQ, Inc. (IONQ) filed a prospectus supplement registering the resale by selling stockholders of up to 13,220,367 shares of common stock. The company will receive no proceeds from these sales. As of August 5, 2025, there were 296,841,308 shares outstanding and the last reported NYSE sale price was $42.02 per share on August 5, 2025.
The supplement discloses detailed selling stockholder positions (including institutional holders such as SK Square and USIT Holdco), escrowed shares related to the ID Quantique acquisition (including 902,160 escrowed shares), and a specified director/officer lock-up period from July 7, 2025 through September 5, 2025. The filing reiterates the companys recent operating losses of $209.1 million and $77.2 million for the six months ended June 30, 2025 and 2024, respectively, and an accumulated deficit of $892.8 million as of June 30, 2025.
IonQ, Inc. filed a prospectus supplement to its Form S-3ASR registration statement (File No. 333-285279) covering the resale by certain selling stockholders of 13,220,367 shares of common stock. A legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP is filed as Exhibit 5.1 and the firm's consent is included as Exhibit 23.1. The filing also includes the cover page interactive data file as Exhibit 104. The prospectus supplement and attached opinion are incorporated by reference into the registration statement to register the resale of the specified shares.
Thomas G. Kramer, Chief Financial Officer of IonQ, Inc. reported the sale of 537,880 shares of common stock on 08/06/2025 pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. The reported weighted average sale price was $41.2804, with individual trades ranging from $40.88 to $43.00. Following these transactions, the reporting person beneficially owns 17,776 shares directly and 5 shares indirectly through a child.
The Form 4 discloses the sale activity and includes an undertaking to provide details on the number of shares sold at each price within the disclosed range upon request.
IonQ, Inc. (IONQ) – Form 4 filing dated 07/24/2025: Director Gabrielle B. Toledano received 3,696 restricted stock units (RSUs) on 07/23/2025. Each RSU converts into one share of common stock at no cost to the director.
Vesting schedule: One-third of the RSUs will vest on 02/24/2026 and on each of the next two annual anniversaries, provided Toledano continues serving on IonQ’s board.
Post-transaction holdings: Toledano now beneficially owns 10,001 common shares, held directly. No share sales or derivative transactions were reported.
The filing represents a routine equity grant meant to align the director’s incentives with shareholders; it has immaterial dilution and does not signal any change in IonQ’s operational or financial outlook.
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
